Ascendis Pharma A/S
NASDAQ:ASND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
Made Tech Group PLC
LSE:MTEC
|
UK |
|
I
|
i3 Interactive Inc
CNSX:BETS
|
CA |
|
Y
|
YD More Investments Ltd
TASE:MRIN
|
IL |
|
QPS Holdings Inc
TSE:464A
|
JP |
|
Magna Terra Minerals Inc
XTSX:MTT
|
CA |
|
Atex Resources Inc
XTSX:ATX
|
CA |
|
R
|
Rosbank PAO
MOEX:ROSB
|
RU |
|
Pan-United Corporation Ltd
SGX:P52
|
SG |
|
A
|
A & W Food Services of Canada Inc
TSX:AW
|
CA |
|
S
|
SIS Distribution Thailand PCL
SET:SIS
|
TH |
|
Redwire Corp
NYSE:RDW
|
US |
Bankruptcy Probability
Ascendis Pharma A/S's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ascendis Pharma A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
14.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ascendis Pharma A/S's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ascendis Pharma A/S has total debt of 442.4m EUR. This includes both short-term (57.1m EUR) and long-term (385.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
